
|Podcasts|November 7, 2019
Episode 43: Pharma Reputation
Author(s)Christen Harm, Elaine Quilici
Sven Klingemann, research director at Reputation Institute talks about pharma’s negative public perception and what the industry can do to improve it.
Advertisement
Sven Klingemann, research director at Reputation Institute talks about pharma’s negative public perception and what the industry can do to improve it.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Amplitude Therapeutics Partners with Eli Lilly
2
Roundup: Amplitude Therapeutics, Chai Discovery Enter Collaborations with Eli Lilly, Bristol Myers Squibb
3
M&A Roundup: IntraGel & UroGen Sign Collaboration & Investment Agreements, Lupin & Tenpoint Form Commercialization Collaboration
4
When Drug Pricing Becomes Trade Policy
5
